{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:12:36Z","timestamp":1770268356542,"version":"3.49.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This review highlights recent advances in the diagnosis and management of children with heart failure. We emphasize the clinical approach to patient care in the areas of acute decompensated heart failure, chronic heart failure, and failure of the patient with single ventricle physiology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Important guidelines regarding the recognition and management of heart failure in children have been proposed and adopted, providing guidance for early recognition and ongoing management. Early diuresis, and avoidance of excessive inotropic agent use, in favor of milrinone as an inotropic-vasodilator agent, are emphasized. Close monitoring of airway pressures to improve ventricular filling, and extubation to positive pressure or high-flow nasal cannula therapy are also important. Chronic heart failure therapy requires combination treatment with diuretics, and the three major classes of drugs. Management of the failing Fontan requires attention to the hepatic, pulmonary and lymphatic circulations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Improved outcomes in children with heart failure are possible. Inherent in this success is the engagement of an interdisciplinary team-based approach to care, with early recognition and escalation of care for specific patients who are not improving as predicted.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000807","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T13:46:02Z","timestamp":1564407962000},"page":"598-603","source":"Crossref","is-referenced-by-count":20,"title":["Update on pediatric heart failure"],"prefix":"10.1097","volume":"31","author":[{"given":"Sylvia","family":"Del Castillo","sequence":"first","affiliation":[{"name":"Department of Anesthesiology Critical Care Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Shaddy","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Southern California Keck School of Medicine, Children's Hospital Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul F.","family":"Kantor","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Southern California Keck School of Medicine, Children's Hospital Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCULATIONAHA.114.001377","article-title":"Changing indications for pediatric heart transplantation: complex congenital heart disease","volume":"131","author":"Hsu","year":"2015","journal-title":"Circulation"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCRESAHA.116.309386","article-title":"Pediatric cardiomyopathies","volume":"121","author":"Lee","year":"2017","journal-title":"Circ Res"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/CIRCHEARTFAILURE.108.772756","article-title":"The \u2018modern\u2019 view of heart failure: how did we get here?","volume":"1","author":"Katz","year":"2008","journal-title":"Circ Heart Fail"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"e898","DOI":"10.1542\/peds.2008-2198","article-title":"Acute heart failure syndromes in the pediatric emergency department","volume":"124","author":"Macicek","year":"2009","journal-title":"Pediatrics"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/chd.12183","article-title":"National prescribing trends for heart failure medications in children","volume":"10","author":"Moffett","year":"2015","journal-title":"Congenital heart disease"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.cjca.2013.08.008","article-title":"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society Guidelines","volume":"29","author":"Kantor","year":"2013","journal-title":"Can J Cardiol"},{"issue":"(3 Suppl 1)","key":"R7-20230918","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/PCC.0000000000000633","article-title":"Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: pharmacotherapies in cardiac critical care fluid management","volume":"17","author":"McCammond","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/anae.14038","article-title":"Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials","volume":"73","author":"Ng","year":"2018","journal-title":"Anaesthesia"},{"key":"R9-20230918","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2019.03.019","article-title":"Diuretic responsiveness and its prognostic significance in children with heart failure","author":"Price","year":"2019","journal-title":"J Card Fail"},{"issue":"(8 Suppl 1)","key":"R10-20230918","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1097\/PCC.0000000000000777","article-title":"C-ritical heart failure shock","volume":"17","author":"Bronicki","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"R11-20230918","first-page":"213","article-title":"Mechanisms and quantitative assessment of drug effects on cardiac output with a new model of the circulation","volume":"33","author":"Greenway","year":"1981","journal-title":"Pharmacol Rev"},{"issue":"(3 Suppl 1)","key":"R12-20230918","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/PCC.0000000000000635","article-title":"Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: pharmacotherapies in cardiac critical care treatment of acute heart failure","volume":"17","author":"Tume","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00246-017-1718-2","article-title":"Use of levosimendan in postoperative setting after surgical repair of congenital heart disease in children","volume":"39","author":"Amiet","year":"2018","journal-title":"Pediatr Cardiol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0735-1097(86)80231-5","article-title":"Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure","volume":"7","author":"Grose","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s001340051286","article-title":"Diastolic function in neonates after the arterial switch operation: effects of positive pressure ventilation and inspiratory time","volume":"26","author":"Meliones","year":"2000","journal-title":"Intensive Care Med"},{"key":"R17-20230918","first-page":"15","article-title":"High-flow nasal cannula versus noninvasive ventilation for postextubation acute respiratory failure after pediatric cardiac surgery","volume":"73","author":"Shioji","year":"2019","journal-title":"Acta Med Okayama"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.athoracsur.2019.01.038","article-title":"Third Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report: preimplant characteristics and outcomes","volume":"107","author":"Morales","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","article-title":"The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: Executive summary [Corrected]","volume":"33","author":"Kirk","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1016\/j.healun.2016.01.440","article-title":"A prospective randomised open-label clinical trial of rapid versus prolonged captopril initiation and up-titration in paediatric cardiology inpatients","volume":"35","author":"Roche","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA Focused Update of the 2013\u200aACCF\/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jacc.2017.07.725","article-title":"Ivabradine in children with dilated cardiomyopathy and symptomatic chronic heart failure","volume":"70","author":"Bonnet","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"New Engl J Med"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ahj.2017.07.006","article-title":"Design for the sacubitril\/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study)","volume":"193","author":"Shaddy","year":"2017","journal-title":"Am Heart J"},{"key":"R26-20230918","first-page":"457","article-title":"Outpatient management of pediatric heart failure","author":"Kantor","year":"2016","journal-title":"Heart failure in the child and young adult from bench to bedside"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/thx.26.3.240","article-title":"Surgical repair of tricuspid atresia","volume":"26","author":"Fontan","year":"1971","journal-title":"Thorax"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fped.2013.00045","article-title":"Reflections on five decades of the fontan kreutzer procedure","volume":"1","author":"Kreutzer","year":"2013","journal-title":"Front Pediatr"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1542\/peds.2013-3949","article-title":"Delayed diagnosis of critical congenital heart defects: trends and associated factors","volume":"134","author":"Liberman","year":"2014","journal-title":"Pediatrics"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1161\/CIRCULATIONAHA.117.028481","article-title":"The optimal timing of stage 2 palliation for hypoplastic left heart syndrome: an analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Data Set","volume":"136","author":"Meza","year":"2017","journal-title":"Circulation"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.amjcard.2013.02.039","article-title":"Staged palliation of hypoplastic left heart syndrome: trends in mortality, cost, and length of stay using a national database from 2000 through 2009","volume":"111","author":"Czosek","year":"2013","journal-title":"Am J Cardiol"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2016.05.035","article-title":"The Fontan epidemic: population projections from the Australia and New Zealand Fontan Registry","volume":"219","author":"Schilling","year":"2016","journal-title":"Int J Cardiol"},{"key":"R33-20230918","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004809","article-title":"Hepatic fibrosis is universal following fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study","volume":"6","author":"Goldberg","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1016\/j.jacc.2017.10.045","article-title":"Fontan-associated liver disease: proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC","volume":"70","author":"Daniels","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.110.981746","article-title":"Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial","volume":"123","author":"Goldberg","year":"2011","journal-title":"Circulation"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCIMAGING.113.001243","article-title":"Sildenafil improves exercise hemodynamics in Fontan patients","volume":"7","author":"Van De Bruaene","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"R37-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2018.03.015","article-title":"Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial","volume":"201","author":"Goldberg","year":"2018","journal-title":"Am Heart J"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"e000865","DOI":"10.1161\/JAHA.114.000865","article-title":"Risk factors and outcome of Fontan-associated plastic bronchitis: a case-control study","volume":"3","author":"Schumacher","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/CEG.S136803","article-title":"Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states","volume":"10","author":"Levitt","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-5223(98)70406-4","article-title":"Protein-losing enteropatthy after the Fontan operation: an international multcentre study","volume":"115","author":"Mertens","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.athoracsur.2009.09.063","article-title":"Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation","volume":"89","author":"Thacker","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2014.04.025","article-title":"Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation","volume":"64","author":"John","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.115.019710","article-title":"Percutaneous lymphatic embolization of abnormal pulmonary lymphatic flow as treatment of plastic bronchitis in patients with congenital heart disease","volume":"133","author":"Dori","year":"2016","journal-title":"Circulation"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.athoracsur.2016.08.110","article-title":"Fontan patient survival after pediatric heart transplantation has improved in the current era","volume":"103","author":"Simpson","year":"2017","journal-title":"Ann Thorac Surg"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:08:48Z","timestamp":1695002928000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000807","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}